Compare H2O America (HTO) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
H2O America vs Regeneron Pharmaceuticals Inc — how do they compare? H2O America trades at $62.03 (market cap $2.61B), while Regeneron Pharmaceuticals Inc trades at $796.8 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 31.4× H2O America's market cap, and H2O America pays the higher dividend (2.83%). Which is the better fit depends on your goals.
| HTO | REGN | |
|---|---|---|
Market Cap | $2.61B | $82.06B |
Sector | Technology | Health |
52-Week High | $65.43 | $812.27 |
52-Week Low | $44.44 | $555.51 |
Enterprise Value | $4.40B | $76.77B |
Dividend Yield | 2.83% | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About H2O America
H2O America is a utility company that provides essential water and wastewater services, primarily in the United States. The company operates a network of regulated water and wastewater systems, focusing on responsible resource management and high-quality service delivery. HTO aims to expand its operational footprint through acquisitions and internal growth, serving residential, commercial, and industrial customers.
Read more on HTO →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
